Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2.
Ong HW, Yang X, Smith JL, Taft-Benz S, Howell S, Dickmander RJ, Havener TM, Sanders MK, Brown JW, Couñago RM, Chang E, Krämer A, Moorman NJ, Heise M, Axtman AD, Drewry DH, Willson TM.
Ong HW, et al. Among authors: yang x.
Molecules. 2024 Sep 2;29(17):4158. doi: 10.3390/molecules29174158.
Molecules. 2024.
PMID: 39275006
Free PMC article.